232 results
Page 5 of 12
6-K
EX-1.1
x2xriz
18 Dec 12
Current report (foreign)
12:00am
6-K
EX-1.2
k5gxty v7s
18 Dec 12
Current report (foreign)
12:00am
424B5
8yotywe24t
14 Dec 12
Prospectus supplement for primary offering
12:00am
424B5
btwn7fyefr h7d
13 Dec 12
Prospectus supplement for primary offering
12:00am
6-K
7djla ylh3
1 Nov 12
Current report (foreign)
12:00am
6-K
EX-99.1
lg17rgwk0yrf 88ds
8 Aug 12
Teva to Initiate Third Phase Iii Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
12:00am
6-K
ivi jvk9sdw0
8 Aug 12
Current report (foreign)
12:00am
6-K
4eq2 n45bjt8yfa
2 Aug 12
Current report (foreign)
12:00am
6-K
72wqcdtqq96 vb7l0ys
9 May 12
Current report (foreign)
12:00am
CORRESP
1gwx 93kobu1pioj
23 Apr 12
Correspondence with SEC
12:00am
6-K
EX-99.1
owjy11
16 Mar 12
Live Filing
12:00am
F-3ASR
EX-4.4
vpse 1z47do2
9 Dec 11
Automatic shelf registration (foreign)
12:00am
F-3ASR
0k8fwrex 7xw
9 Dec 11
Automatic shelf registration (foreign)
12:00am
F-3ASR
EX-4.5
qwwgg1ph
9 Dec 11
Automatic shelf registration (foreign)
12:00am
F-3ASR
EX-4.3
4if6l18idsyo
9 Dec 11
Automatic shelf registration (foreign)
12:00am
F-3ASR
EX-4.6
sa7qrno
9 Dec 11
Automatic shelf registration (foreign)
12:00am
6-K
EX-1.2
y3p4ik4jxfbi7f1e
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.3
gdsxft502h
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.1
07qdh95l8rjap
10 Nov 11
Current report (foreign)
12:00am